683 Capital Management, LLC / PHAT
683 Capital Management, LLC’s Phathom Pharmaceuticals Inc Position
Does 683 Capital Management, LLC own Phathom Pharmaceuticals Inc (PHAT)? Yes — 1.85M shares worth $21M (+1.07% of its 13F portfolio) as of Q1 2026, up from 1.78M shares the prior filed quarter.
Position Value
$21M
Q1 2026
Shares
1.85M
% of Portfolio
+1.07%
Quarters Held
18
currently held
Position History PHAT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.85M | $21M | +1.07% |
| Q4 2025 | 1.78M | $30M | +1.29% |
| Q3 2025 | 1.82M | $21M | +1.12% |
| Q2 2025 | 2.10M | $20M | +1.33% |
| Q1 2025 | 1.45M | $9M | +0.62% |
| Q4 2024 | 1.02M | $8M | +0.52% |
| Q3 2024 | 1.01M | $18M | +1.39% |
| Q2 2024 | 1.40M | $14M | +1.09% |
| Q1 2024 | 1.65M | $18M | +1.28% |
| Q4 2023 | 1.28M | $12M | +0.96% |
| Q3 2023 | 1.10M | $11M | +0.89% |
| Q2 2023 | 1.29M | $18M | +1.32% |
| Q1 2023 | 1.33M | $9M | +0.70% |
| Q4 2022 | 1.35M | $15M | +1.28% |
| Q3 2022 | 1.66M | $18M | +1.42% |
| Q2 2022 | 1.44M | $12M | +0.86% |
| Q1 2022 | 355.0K | $5M | +0.26% |
| Q4 2021 | 290.6K | $6M | +0.21% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See 683 Capital Management, LLC’s full portfolio or all institutional holders of PHAT.